Norges Bank’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $4.67M | Hold |
|
|||||
|
2023
Q1 | $4.9M | Sell |
|
|||||
|
2022
Q4 | $6.12M | Hold |
|
|||||
|
2022
Q3 | $5.53M | Hold |
|
|||||
|
2022
Q2 | $4.94M | Buy |
|
|||||
|
2022
Q1 | $5.1M | Hold |
|
|||||
|
2021
Q4 | $5.89M | Buy |
|
|||||
|
2021
Q3 | $1.79M | Sell |
|
|||||
|
2021
Q2 | $5.96M | Sell |
|
|||||
|
2021
Q1 | $10.4M | Sell |
|
|||||
|
2020
Q4 | $11.7M | Sell |
|
|||||
|
2020
Q3 | $14.9M | Sell |
|
|||||
|
2020
Q2 | $26.4M | Buy |
|
|||||
|
2020
Q1 | $24.4M | Sell |
|
|||||
|
2019
Q4 | $27.8M | Buy |
|
|||||
|
2019
Q3 | $18.6M | Buy |
|
|||||
|
2019
Q2 | $15.2M | Buy |
|
|||||
|
2019
Q1 | $19.9M | Hold |
|
|||||
|
2018
Q4 | $22.4M | Buy |
|
|||||
|
2018
Q3 | $27.4M | Buy |
|
|||||
|
2018
Q2 | $18.1M | Buy |
|
|||||
|
2018
Q1 | $17.4M | Sell |
|
|||||
|
2017
Q4 | $21.6M | Sell |
|
|||||
|
2017
Q3 | $27.5M | Hold |
|
|||||
|
2017
Q2 | $32M | Hold |
|
|||||
|
2017
Q1 | $29.6M | Sell |
|
|||||
|
2016
Q4 | $27.6M | Hold |
|
|||||
|
2016
Q3 | $30M | Buy |
|
|||||
|
2016
Q2 | $10.7M | Buy |
|
|||||
|
2016
Q1 | $6.44M | Sell |
|
|||||
|
2015
Q4 | $6.74M | Sell |
|
|||||
|
2015
Q3 | $8.68M | Sell |
|
|||||
|
2015
Q2 | $13M | Buy |
|
|||||
|
2015
Q1 | $15.8M | Buy |
|
|||||
|
2014
Q4 | $3.67M | Hold |
|
|||||
|
2014
Q3 | $5.66M | Sell |
|
|||||
|
2014
Q2 | $15.7M | Buy |
|